Dopamine agonist therapy for prolactinomas: do we need to rethink the place of surgery in prolactinoma management?
{{output}}
The current treatment paradigm for prolactinomas involves dopamine agonist (DA) therapy as the first-line treatment, with surgical resection reserved for cases where there is DA failure due to resistance or intolerance. This review highlights how DA therapy ca... ...
